[Bacterial multi-resistence and therapeutic possibilities based on laboratory results].
D001414:Bacitracin / Q000494:pharmacology; D002228:Carbenicillin / Q000494:pharmacology; D002512:Cephalothin / Q000494:pharmacology; D003091:Colistin / Q000494:pharmacology; D004754:Enterobacter / Q000187:drug effects; D004755:Enterobacteriaceae / Q000187:drug effects; D004917:Erythromycin / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects; D005839:Gentamicins / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000494:pharmacology; D009355:Neomycin / Q000494:pharmacology; D009582:Nitrofurantoin / Q000494:pharmacology; D011113:Polymyxins / Q000494:pharmacology; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013420:Sulfamethoxazole / Q000494:pharmacology
D005839:Gentamicins; D011113:Polymyxins; D001414:Bacitracin; D009268:Nalidixic Acid; D004917:Erythromycin; D009582:Nitrofurantoin; D002228:Carbenicillin; D009355:Neomycin; D013420:Sulfamethoxazole; D002512:Cephalothin; D003091:Colistin
Bakterielle Mehrfachresistenz und therapeutische Möglichkeiten aufgrund von Laboratoriumserfahrungen.